Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Mönchengladbach
Clinical trial register · Germany

Clinical Trials in Mönchengladbach, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca3 Sanofi Pasteur, a Sanofi Company2 Christian Buske2 Merck Sharp & Dohme LLC1 Epizyme, Inc.1
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Mönchengladbach

27 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
AstraZeneca
Phase 3
150
Berlin, Düsseldorf, Erlangen, Freiburg im Breisgau, Mönchengladbach, München, Paderborn, Trier
2026-06-15
Recruiting
Women's Cancer Study Group GmbH
Phase 3
250
Cologne, Essen, Mönchengladbach, Münster, Frankfurt, Hamburg, Hildesheim, München
2025-11-27
Active, closed
Sanofi
Phase 3
1,092
Herxheim, Hürth, Krefeld, Mönchengladbach, Schönau am Königssee, Wolfsburg
2025-05-22
Recruiting
Christian Buske
Phase 2
80
Bielefeld, Chemnitz, Kempten, Kiel, Koblenz, Landshut, Mönchengladbach, Mutlangen
2025-03-21
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 1/2
750
Herxheim, Hürth, Krefeld, Mönchengladbach, Schönau am Königssee, Wolfsburg
2024-11-05
Recruiting
Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis
NCT07426991Multiple Sclerosis, Remitting-Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progress Multiple Sclerosis
Heinrich-Heine University, Duesseldorf
Observational
837
Düsseldorf, Mönchengladbach
2024-11-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Essen, Bottrop, Dresden, Leipzig, Mönchengladbach, München, Münster, Wolfsburg
2024-07-31
Recruiting
PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
NCT06102057Stage III Non-small Cell Lung Cancer, Locally Advanced, Unresectable
TheraOp
Phase 2
110
Dresden, Essen, Freiburg im Breisgau, Göttingen, Homburg, Mönchengladbach, München, Oldenburg
2024-07-01
Recruiting
Lohmann & Rauscher
Observational
208
Aachen, Brüggen, Dortmund, Erlangen, Hamburg, Mönchengladbach, Waidhaus, Willich
2024-03-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Ulm, Landshut, Mönchengladbach, Koblenz, Halle, Berlin
2023-12-13
Recruiting
Universität des Saarlandes
Phase 2
43
Augsburg, Erlangen, Regensburg, Mönchengladbach, Homburg
2023-10-06
Active, closed
University of Leipzig
Phase 2
45
Berlin, Chemnitz, Cottbus, Dresden, Heidelberg, Leipzig, Mönchengladbach, München
2023-05-17
Recruiting
Filter Lifespan in Continuous Renal Replacement Therapy
NCT05450185Critically Ill, Continuous Renal Replacement Therapy, Infections
University Hospital Muenster
Observational
600
Erlangen, Mönchengladbach, Münster
2023-03-02
Active, closed
Sanofi Pasteur, a Sanofi Company
Phase 3
209
Bönnigheim, Bramsche, Bretten, Erfurt, Goch, Hamburg, Mönchengladbach, Schönau am Königssee
2022-08-23
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Muenchen, Halle, Essen, Frankfurt, Mönchengladbach, Münster, Tübingen
2022-08-17
Recruiting
Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody
NCT05045664Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a
Heidelberg University
Phase 3
100
Berlin, Essen, Göttingen, Heidelberg, Mönchengladbach, Munich, Regensburg, Rostock
2022-07-06
Active, closed
AstraZeneca
Phase 3
927
Augsburg, Berlin, Erlangen, Hamburg, Heidelberg, Kiel, Leipzig, Mönchengladbach
2021-10-25
Recruiting
Occlutech International AB
Observational
685
Erlangen, Mönchengladbach, München
2021-10-14
Active, closed
Eli Lilly and Company
Phase 3
874
Ludwigsburg, Donauwörth, Erlangen, München, Frankfurt am Main, Hanover, Essen, Mönchengladbach
2021-10-04
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Amberg, Berlin, Bochum, Dresden, Frankfurt am Main, Hamburg, Herne, Mönchengladbach
2021-06-24
Active, closed
AstraZeneca
Phase 3
1,371
Berlin, Dessau-RoBlau, Essen, Freiburg im Breisgau, Mönchengladbach, München, Münster, Regensburg
2021-01-28
Active, closed
Hoffmann-La Roche
Phase 2
920
Essen, Göttingen, Heilbronn, Mönchengladbach
2021-01-18
Active, closed
German CLL Study Group
Phase 2
42
Augsburg, Cologne, Esslingen am Neckar, Hamm, Homburg, Kiel, Mönchengladbach, Munich
2020-10-01
Active, closed
Epizyme, Inc.
Phase 3
599
Schwäbisch Hall, München, Mainz, Bonn, Mönchengladbach, Kiel, Berlin
2020-06-11
Active, closed
Christian Buske
Phase 2
53
Bielefeld, Bremen, Halle, Mannheim, Mönchengladbach, Mutlangen, München, Münster
2019-09-11
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
2,000
Aachen, Bayreuth, Dresden, Mönchengladbach, München
2019-06-24
Recruiting
Abbott Medical Devices
Observational
2,000
Tübingen, Ingolstadt, Cologne, Duisburg, Düsseldorf, Mönchengladbach, Lübeck, Gera
2019-03-13
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/m-nchengladbach

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Mönchengladbach.

How many clinical trials are recruiting in Mönchengladbach?

13 of the 27 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Mönchengladbach), 27 studies
PhaseStudiesRecruitingShare
Phase 312444.4%
Phase 28329.6%
Observational6622.2%
Phase 1/2103.7%

Most active sponsors

Lead sponsors with the most studies (Mönchengladbach)
Lead sponsorStudiesRecruiting
AstraZeneca31
Christian Buske21
Sanofi Pasteur, a Sanofi Company20
Abbott Medical Devices11
Astellas Pharma Global Development, Inc.10
Eli Lilly and Company10
EMD Serono Research & Development Institute, Inc.10
Epizyme, Inc.10
European Organisation for Research and Treatment of Cancer - EORTC11
German CLL Study Group10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.